These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 36847263

  • 1. Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration.
    Li S, Zhu S, Xie F.
    J Pharm Pharmacol; 2023 Apr 07; 75(4):515-522. PubMed ID: 36847263
    [Abstract] [Full Text] [Related]

  • 2. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Lefrant JY, Roberts JA.
    Antimicrob Agents Chemother; 2016 Aug 07; 60(8):4901-9. PubMed ID: 27270279
    [Abstract] [Full Text] [Related]

  • 3. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N, Mbatchi LC, Maseda E, Luque S, Grau S, Wallis SC, Muller L, Lipman J, Roberts JA, Lefrant JY, Roger C.
    Ther Drug Monit; 2021 Dec 01; 43(6):747-755. PubMed ID: 33560097
    [Abstract] [Full Text] [Related]

  • 4. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J, Min KL, Kang S, Yang S, Park MS, Wi J, Chang MJ.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0063321. PubMed ID: 34937189
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
    Patel K, Roberts JA, Lipman J, Tett SE, Deldot ME, Kirkpatrick CM.
    Antimicrob Agents Chemother; 2011 Dec 22; 55(12):5868-73. PubMed ID: 21930888
    [Abstract] [Full Text] [Related]

  • 6. A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration.
    Sime FB, Lassig-Smith M, Starr T, Stuart J, Pandey S, Parker SL, Wallis SC, Lipman J, Roberts JA.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31658965
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
    Roger C, Muller L, Wallis SC, Louart B, Saissi G, Lipman J, Lefrant JY, Roberts JA.
    J Antimicrob Chemother; 2016 Feb 20; 71(2):464-70. PubMed ID: 26538503
    [Abstract] [Full Text] [Related]

  • 8. Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements.
    Ulldemolins M, Martín-Loeches I, Llauradó-Serra M, Fernández J, Vaquer S, Rodríguez A, Pontes C, Calvo G, Torres A, Soy D.
    J Antimicrob Chemother; 2016 Jun 20; 71(6):1651-9. PubMed ID: 26869692
    [Abstract] [Full Text] [Related]

  • 9. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
    D'Arcy DM, Casey E, Gowing CM, Donnelly MB, Corrigan OI.
    BMC Pharmacol Toxicol; 2012 Nov 08; 13():14. PubMed ID: 23136834
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF).
    Gatti M, Rinaldi M, Tonetti T, Gaibani P, Siniscalchi A, Viale P, Pea F.
    Int J Antimicrob Agents; 2023 Aug 08; 62(2):106852. PubMed ID: 37192727
    [Abstract] [Full Text] [Related]

  • 11. Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    He S, Cheng Z, Xie F.
    Drug Des Devel Ther; 2022 Aug 08; 16():13-22. PubMed ID: 35023902
    [Abstract] [Full Text] [Related]

  • 12. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
    Carrié C, Delzor F, Roure S, Dubuisson V, Petit L, Molimard M, Breilh D, Biais M.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964795
    [Abstract] [Full Text] [Related]

  • 13. Optimized meropenem dosage regimens using a pharmacokinetic/pharmacodynamic population approach in patients undergoing continuous venovenous haemodiafiltration with high-adsorbent membrane.
    Padullés Zamora A, Juvany Roig R, Leiva Badosa E, Sabater Riera J, Pérez Fernández XL, Cárdenas Campos P, Rigo Bonin R, Alía Ramos P, Tubau Quintano F, Sospedra Martinez E, Colom Codina H.
    J Antimicrob Chemother; 2019 Oct 01; 74(10):2979-2983. PubMed ID: 31335959
    [Abstract] [Full Text] [Related]

  • 14. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Peng Y, Cheng Z, Xie F.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0082222. PubMed ID: 36005753
    [Abstract] [Full Text] [Related]

  • 15. Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
    Kirwan M, Munshi R, O'Keeffe H, Judge C, Coyle M, Deasy E, Kelly YP, Lavin PJ, Donnelly M, D'Arcy DM.
    Crit Care; 2021 Dec 20; 25(1):443. PubMed ID: 34930430
    [Abstract] [Full Text] [Related]

  • 16. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A, Ferriols-Lisart R, Aguilar G, Ezquer-Garín C, Belda FJ, Guglieri-López B.
    Int J Antimicrob Agents; 2018 Jan 20; 51(1):115-121. PubMed ID: 28666752
    [Abstract] [Full Text] [Related]

  • 17. A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF).
    Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Giannella M, Viale P, Pea F.
    J Crit Care; 2023 Aug 20; 76():154301. PubMed ID: 37059003
    [Abstract] [Full Text] [Related]

  • 18. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA, Udy AA, Bulitta JB, Stuart J, Jarrett P, Starr T, Lassig-Smith M, Roberts NA, Dunlop R, Hayashi Y, Wallis SC, Lipman J.
    J Antimicrob Chemother; 2014 Sep 20; 69(9):2508-16. PubMed ID: 24879665
    [Abstract] [Full Text] [Related]

  • 19. A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients.
    Hanafin PO, Kwa A, Zavascki AP, Sandri AM, Scheetz MH, Kubin CJ, Shah J, Cherng BPZ, Yin MT, Wang J, Wang L, Calfee DP, Bolon M, Pogue JM, Purcell AW, Nation RL, Li J, Kaye KS, Rao GG.
    Clin Microbiol Infect; 2023 Sep 20; 29(9):1174-1181. PubMed ID: 37217076
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration.
    Spooner AM, Deegan C, D'Arcy DM, Gowing CM, Donnelly MB, Corrigan OI.
    BMC Clin Pharmacol; 2011 Aug 04; 11():11. PubMed ID: 21816053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.